Drugs / Enecadin
Enecadin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00331721 Comparator | May 2006 → May 2009 | ischemic stroke | PAION Deutschland GmbH | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enecadin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00331721 ↗ |
| Known as | Enecadina | ChEMBL registry synonym — accepted as the source's own label CHEMBL29404 ↗ |
| Known as | Enecadine | ChEMBL registry synonym — accepted as the source's own label CHEMBL29404 ↗ |
| Modality | Small molecule | — CHEMBL29404 ↗ |